Oral Estrogen Therapy and Its Association with Porphyria Cutanea Tarda: Insights from a Danish Nationwide Study
A large Danish case-control study finds oral estrogen-containing therapies double the risk of incident porphyria cutanea tarda in women, highlighting the importance of administration route in risk assessment.